SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-040876
Filing Date
2021-02-12
Accepted
2021-02-12 13:00:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d133259dsc13ga.htm SC 13G/A 33114
  Complete submission text file 0001193125-21-040876.txt   34497
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90685 | Film No.: 21625033
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 811 STRADA VECCHIA LOS ANGELES CA 90077
Business Address 811 STRADA VECCHIA LOS ANGELES CA 90077 650-457-2700
Seaview Trust (Filed by) CIK: 0001767779 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A